Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT02276885

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

Conditions: Breast Cancer

Sex: Female
Ages: 50 Years – 90 Years
Healthy volunteers: No
Phase: NA
Enrollment: 284
Sponsor: NYU Langone Health

Location: NYU Langone Medical Center New York New York

Summary

The purpose of this study is to test whether a radiotherapy regimen of 8 GY x 3 days over 5 days (every other day) is as safe (well-tolerated) and effective as 6 Gy x 5 over five consecutive days

Eligibility Criteria

Inclusion Criteria: * Post-menopausal women defined as either: 1. at least 2 years without menstrual period 2. patients older than 50 with serological evidence of post-menopausal status 3. hysterectomized patients of any age with FSH confirmation of post- menopausal status * pT1 breast cancer, excised with negative margins. Criteria for low risk-pTis: 1. Screen-detected 2. Low to intermediate nuclear grade 3. \< 2.5cm in size 4. Resected with negative margins at \>3mm) * clinically N0 or pN0 or sentinel node negative breast cancer Exclusion Criteria: * previous radiation therapy to the ipsilateral breast * presence of a proportion of DCIS in the core biopsy specimen which is compatible with extensive intraductal component (EIC)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02276885). StuddyBuddy aggregates publicly available trial information.